Ludwig Hantson Net Worth & Insider Trades
Ludwig Hantson - CEO, Alexion Pharmaceuticals, Inc
What is Ludwig Hantson's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals, Inc's CEO, Ludwig Hantson, is estimated to be about $35.91M . Ludwig Hantson owns about 150,696 units of Alexion Pharmaceuticals, Inc common stock. In the last 4 years at Alexion Pharmaceuticals, Inc, Ludwig Hantson has sold an estimated value of $20.48M worth.
What is Ludwig Hantson's Past Insider Trading?
Ludwig Hantson's largest purchase order was 10,000 units , worth over $1.17M on June 19, 2017. Ludwig Hantson's largest sale order was 13,245 units , worth over $1.54M on February 8, 2018. In total, Ludwig Hantson has made about 17 transactions over 4 years of their time at Alexion Pharmaceuticals, Inc. Ludwig Hantson usually trades in March, with the busiest year in 2019, 2021 and 2020. The most recent transaction was a sale order of 3,244 units , worth over $310.94K on January 3, 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ludwig Hantson
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Ludwig Hantson's Salary in 2019?
As CEO of Alexion Pharmaceuticals, Inc, Ludwig Hantson has a total base salary of $1,250,000 . Ludwig Hantson received compensation valued at about $18,947,984 in 2019 after becoming CEO. The vast majority of their compensation came in the form of stock awards of $15,243,634 , other earnings, plans or compensations of $2,430,000 , and other compensation of $24,350 .
What is Ludwig Hantson's' Mailing Address?
- Mailing address is C/o Alexion Pharmaceuticals, Inc 100 College Street New Haven CT 06510 CT
Alexion Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
| Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
| Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
| Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
| Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
| Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
| Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
| Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
| Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
| Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
| Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
| Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
| Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
| John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
| John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
| John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals, Inc's Past Insider Trades?
Alexion Pharmaceuticals, Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals, Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||